BioWorld

Aug. 8, 2008

View Archived Issues

Ahead of OncoGenex Merger, Sonus Adds Caspase Program

Read More

Compliance in Off-Label and Journal Articles

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Appointments And Advancements

Read More

Celgene Calls it Quits in GPC Satraplatin Deal

Celgene Corp. has ended its nearly three-year partnership with embattled German firm GPC Biotech AG on its prostate cancer drug satraplatin. (BioWorld Today) Read More

Acorda's $114M Offering to Support NDA, Launch

Read More